340B Legislative and Regulatory Update

The 340B Drug Pricing Program helps Montana hospitals and community health centers stretch limited resources to serve rural and underserved patients—and the program continues to face pressure from Congress, federal regulators and drug manufacturers. This session gave attendees an update on recent legislative activity and regulatory developments affecting 340B, along with practical considerations for protecting program savings.